{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T05:52:05Z","timestamp":1794808325515,"version":"4.9.1"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T00:00:00Z","timestamp":1713312000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100018920","name":"Shanghai Jiao Tong University Medical School Affiliated Ruijin Hospital","doi-asserted-by":"publisher","award":["2019ZX01"],"award-info":[{"award-number":["2019ZX01"]}],"id":[{"id":"10.13039\/501100018920","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.biopha.2024.116617","type":"journal-article","created":{"date-parts":[[2024,4,20]],"date-time":"2024-04-20T05:10:15Z","timestamp":1713589815000},"page":"116617","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["A high-dose of ursodeoxycholic acid treatment alleviates liver inflammation by remodeling gut microbiota and bile acid profile in a mouse model of non-alcoholic steatohepatitis"],"prefix":"10.1016","volume":"174","author":[{"given":"Hu","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5680-2390","authenticated-orcid":false,"given":"Mingjie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peizhan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyu","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.biopha.2024.116617_bib1","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1016\/j.mayocp.2022.04.005","article-title":"Nonalcoholic fatty liver disease: review of management for primary care providers","volume":"97","author":"Basu","year":"2022","journal-title":"Mayo Clin. Proc."},{"issue":"12","key":"10.1016\/j.biopha.2024.116617_bib2","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1001\/jama.2020.2298","article-title":"Nonalcoholic steatohepatitis: a review","volume":"323","author":"Sheka","year":"2020","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.biopha.2024.116617_bib3","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"issue":"11","key":"10.1016\/j.biopha.2024.116617_bib4","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1038\/s41395-018-0088-6","article-title":"NASH leading cause of liver transplant in women: updated analysis of indications for liver transplant and ethnic and gender variances","volume":"113","author":"Noureddin","year":"2018","journal-title":"Am. J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.biopha.2024.116617_bib5","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American association for the study of liver diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.biopha.2024.116617_bib6","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1007\/s00125-011-2446-4","article-title":"Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of randomised trials","volume":"55","author":"Musso","year":"2012","journal-title":"Diabetologia"},{"issue":"2","key":"10.1016\/j.biopha.2024.116617_bib7","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1053\/j.gastro.2015.04.005","article-title":"Weight loss through lifestyle modification significantly reduces features of nonalcoholic steatohepatitis","volume":"149","author":"Vilar-Gomez","year":"2015","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.biopha.2024.116617_bib8","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/s41575-020-0269-9","article-title":"Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders","volume":"17","author":"Aron-Wisnewsky","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"2","key":"10.1016\/j.biopha.2024.116617_bib9","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nrgastro.2017.119","article-title":"Bile acid-microbiota crosstalk in gastrointestinal inflammation and carcinogenesis","volume":"15","author":"Jia","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.biopha.2024.116617_bib10","article-title":"Serum glycocholic acid-to-total bile acid ratio is independently associated with nonalcoholic fatty liver disease: a retrospective cross-sectional study","author":"Li","year":"2021","journal-title":"BioMed. Res. Int."},{"key":"10.1016\/j.biopha.2024.116617_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.788558","article-title":"Ursodeoxycholic Acid Treatment Restores Gut Microbiota and Alleviates Liver Inflammation in Non-Alcoholic Steatohepatitic Mouse Model","volume":"12","author":"Li","year":"2021","journal-title":"Front Pharm."},{"key":"10.1016\/j.biopha.2024.116617_bib12","doi-asserted-by":"crossref","unstructured":"EASL Clinical practice guidelines: the diagnosis and management of patients with primary biliary cholangitis, Journal of hepatology 67(1), 2017. pp. 145-172. .","DOI":"10.1016\/j.jhep.2017.03.022"},{"issue":"5","key":"10.1016\/j.biopha.2024.116617_bib13","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.jhep.2010.08.030","article-title":"A randomized controlled trial of high-dose ursodesoxycholic acid for nonalcoholic steatohepatitis","volume":"54","author":"Ratziu","year":"2011","journal-title":"J. Hepatol."},{"issue":"3","key":"10.1016\/j.biopha.2024.116617_bib14","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1002\/hep.20092","article-title":"Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: results of a randomized trial","volume":"39","author":"Lindor","year":"2004","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.biopha.2024.116617_bib15","first-page":"1464","article-title":"Ursodeoxycholic acid or clofibrate in the treatment of non-alcohol-induced steatohepatitis: a pilot study","volume":"23","author":"Laurin","year":"1996","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.biopha.2024.116617_bib16","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"issue":"17","key":"10.1016\/j.biopha.2024.116617_bib17","doi-asserted-by":"crossref","first-page":"i884","DOI":"10.1093\/bioinformatics\/bty560","article-title":"fastp: an ultra-fast all-in-one FASTQ preprocessor","volume":"34","author":"Chen","year":"2018","journal-title":"Bioinformatics"},{"issue":"21","key":"10.1016\/j.biopha.2024.116617_bib18","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1093\/bioinformatics\/btr507","article-title":"FLASH: fast length adjustment of short reads to improve genome assemblies","volume":"27","author":"Magoc","year":"2011","journal-title":"Bioinformatics"},{"issue":"10","key":"10.1016\/j.biopha.2024.116617_bib19","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1038\/nmeth.2604","article-title":"UPARSE: highly accurate OTU sequences from microbial amplicon reads","volume":"10","author":"Edgar","year":"2013","journal-title":"Nat. Methods"},{"issue":"16","key":"10.1016\/j.biopha.2024.116617_bib20","doi-asserted-by":"crossref","DOI":"10.1128\/AEM.00062-07","article-title":"Naive Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy","volume":"73","author":"Wang","year":"2007","journal-title":"Appl. Environ. Microbiol."},{"issue":"6","key":"10.1016\/j.biopha.2024.116617_bib21","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/s41587-020-0548-6","article-title":"PICRUSt2 for prediction of metagenome functions","volume":"38","author":"Douglas","year":"2020","journal-title":"Nat. Biotechnol."},{"issue":"6","key":"10.1016\/j.biopha.2024.116617_bib22","doi-asserted-by":"crossref","first-page":"R60","DOI":"10.1186\/gb-2011-12-6-r60","article-title":"Metagenomic biomarker discovery and explanation","volume":"12","author":"Segata","year":"2011","journal-title":"Genome Biol."},{"issue":"1","key":"10.1016\/j.biopha.2024.116617_bib23","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s40793-020-00358-7","article-title":"Tax4Fun2: prediction of habitat-specific functional profiles and functional redundancy based on 16S rRNA gene sequences","volume":"15","author":"Wemheuer","year":"2020","journal-title":"Environ. Microbiome"},{"issue":"11","key":"10.1016\/j.biopha.2024.116617_bib24","article-title":"Beneficial effects of UDCA and norUDCA in a rodent model of steatosis are linked to modulation of GPBAR1\/FXR signaling","volume":"1867","author":"Marchiano","year":"2022","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"issue":"10","key":"10.1016\/j.biopha.2024.116617_bib25","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/j.bbalip.2019.07.006","article-title":"Ursodeoxycholic acid is a GPBAR1 agonist and resets liver\/intestinal FXR signaling in a model of diet-induced dysbiosis and NASH","volume":"1864","author":"Carino","year":"2019","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"issue":"9","key":"10.1016\/j.biopha.2024.116617_bib26","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1001\/jamainternmed.2019.2248","article-title":"Association of weight loss interventions with changes in biomarkers of nonalcoholic fatty liver disease: a systematic review and meta-analysis","volume":"179","author":"Koutoukidis","year":"2019","journal-title":"JAMA Intern. Med."},{"issue":"2","key":"10.1016\/j.biopha.2024.116617_bib27","doi-asserted-by":"crossref","first-page":"386","DOI":"10.3390\/nu14020386","article-title":"Switching to regular diet partially resolves liver fibrosis induced by high-fat, high-cholesterol diet in mice","volume":"14","author":"Farooq","year":"2022","journal-title":"Nutrients"},{"issue":"2","key":"10.1016\/j.biopha.2024.116617_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0246161","article-title":"Secondary bile acid ursodeoxycholic acid alters weight, the gut microbiota, and the bile acid pool in conventional mice","volume":"16","author":"Winston","year":"2021","journal-title":"PLOS One"},{"issue":"7075","key":"10.1016\/j.biopha.2024.116617_bib29","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/nature04330","article-title":"Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation","volume":"439","author":"Watanabe","year":"2006","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.biopha.2024.116617_bib30","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1002\/jcp.25742","article-title":"TUDCA: an agonist of the bile acid receptor GPBAR1\/TGR5 with anti-inflammatory effects in microglial cells","volume":"232","author":"Yanguas-Cas\u00e1s","year":"2017","journal-title":"J. Cell. Physiol."},{"issue":"12","key":"10.1016\/j.biopha.2024.116617_bib31","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1038\/s41591-018-0222-4","article-title":"Gut microbiota and intestinal FXR mediate the clinical benefits of metformin","volume":"24","author":"Sun","year":"2018","journal-title":"Nat. Med."},{"issue":"7","key":"10.1016\/j.biopha.2024.116617_bib32","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1042\/CS20220674","article-title":"Potential therapeutic action of tauroursodeoxycholic acid against cholestatic liver injury via hepatic Fxr\/Nrf2 and CHOP-DR5-caspase-8 pathway","volume":"137","author":"Song","year":"2023","journal-title":"Clin. Sci."},{"issue":"2","key":"10.1016\/j.biopha.2024.116617_bib33","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/SHK.0000000000001351","article-title":"TUDCA Ameliorates liver injury via activation of SIRT1-FXR signaling in a rat hemorrhagic shock model","volume":"53","author":"Sun","year":"2020","journal-title":"Shock"},{"key":"10.1016\/j.biopha.2024.116617_bib34","article-title":"Integrative analysis of gut microbiota and fecal metabolites in metabolic associated fatty liver disease patients","volume":"13","author":"Yang","year":"2022","journal-title":"Front. Microbiol."},{"issue":"6","key":"10.1016\/j.biopha.2024.116617_bib35","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1021\/pr400263n","article-title":"Gut microbiota composition modifies fecal metabolic profiles in mice","volume":"12","author":"Zhao","year":"2013","journal-title":"J. Proteome Res."},{"issue":"3","key":"10.1016\/j.biopha.2024.116617_bib36","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1002\/hep.28356","article-title":"The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota","volume":"63","author":"Boursier","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.biopha.2024.116617_bib37","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2020.567654","article-title":"Microbial metabolites: critical regulators in NAFLD","volume":"11","author":"Dai","year":"2020","journal-title":"Front. Microbiol."},{"issue":"7","key":"10.1016\/j.biopha.2024.116617_bib38","doi-asserted-by":"crossref","DOI":"10.14309\/ctg.0000000000000503","article-title":"Association of serum and fecal bile acid patterns with liver fibrosis in biopsy-proven nonalcoholic fatty liver disease: an observational study","volume":"13","author":"Kasai","year":"2022","journal-title":"Clin. Transl. Gastroenterol."},{"issue":"3","key":"10.1016\/j.biopha.2024.116617_bib39","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/bph.14095","article-title":"Tauroursodeoxycholic acid inhibits intestinal inflammation and barrier disruption in mice with non-alcoholic fatty liver disease","volume":"175","author":"Wang","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.biopha.2024.116617_bib40","doi-asserted-by":"crossref","first-page":"842","DOI":"10.3389\/fphar.2019.00842","article-title":"Ursodeoxycholic acid alters bile acid and fatty acid profiles in a mouse model of diet-induced obesity","volume":"10","author":"Zhang","year":"2019","journal-title":"Front. Pharmacol."},{"issue":"3","key":"10.1016\/j.biopha.2024.116617_bib41","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1002\/j.2040-4603.2013.tb00517.x","article-title":"Bile acid metabolism and signaling","volume":"3","author":"Chiang","year":"2013","journal-title":"Compr. Physiol."},{"issue":"6","key":"10.1016\/j.biopha.2024.116617_bib42","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1002\/hep.32568","article-title":"Metabolic reprogramming of the intestinal microbiome with functional bile acid changes underlie the development of NAFLD","volume":"76","author":"Smirnova","year":"2022","journal-title":"Hepatology"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224005018?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224005018?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T23:15:26Z","timestamp":1782342926000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332224005018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":42,"alternative-id":["S0753332224005018"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2024.116617","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A high-dose of ursodeoxycholic acid treatment alleviates liver inflammation by remodeling gut microbiota and bile acid profile in a mouse model of non-alcoholic steatohepatitis","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2024.116617","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"116617"}}